Senators see room for more PhRMA healthcare reform concessions in importation debate
This article was originally published in Scrip
Executive Summary
US Senate negotiations over a drug importation amendment to healthcare reform legislation could lead to industry concessions beyond PhRMA's original $80 billion deal with the White House, two Democratic senators suggested on December 11th.